EGF Theramed Health (OTCMKTS:EVAHF – Get Free Report) and Phreesia (NYSE:PHR – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation.
Profitability
This table compares EGF Theramed Health and Phreesia’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| EGF Theramed Health | N/A | N/A | N/A |
| Phreesia | 1.85% | 5.13% | 3.12% |
Earnings and Valuation
This table compares EGF Theramed Health and Phreesia”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| EGF Theramed Health | N/A | N/A | N/A | N/A | N/A |
| Phreesia | $480.59 million | 1.47 | $2.31 million | $0.15 | 76.43 |
Phreesia has higher revenue and earnings than EGF Theramed Health.
Institutional and Insider Ownership
92.1% of Phreesia shares are held by institutional investors. 5.2% of Phreesia shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of recent ratings for EGF Theramed Health and Phreesia, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| EGF Theramed Health | 0 | 0 | 0 | 0 | 0.00 |
| Phreesia | 1 | 9 | 9 | 0 | 2.42 |
Phreesia has a consensus target price of $16.65, indicating a potential upside of 45.20%. Given Phreesia’s stronger consensus rating and higher possible upside, analysts plainly believe Phreesia is more favorable than EGF Theramed Health.
Summary
Phreesia beats EGF Theramed Health on 9 of the 9 factors compared between the two stocks.
About EGF Theramed Health
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company is headquartered in Vancouver, Canada.
About Phreesia
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Receive News & Ratings for EGF Theramed Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EGF Theramed Health and related companies with MarketBeat.com's FREE daily email newsletter.
